These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 23802311)

  • 1. Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone-only pill.
    Palacios S; Colli E; Regidor PA
    Acta Obstet Gynecol Scand; 2019 Dec; 98(12):1549-1557. PubMed ID: 31321765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drospirenone-containing oral contraceptives may increase the risk of venous thromboembolism.
    Jick SS
    Evid Based Nurs; 2014 Jul; 17(3):71. PubMed ID: 24170817
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute myocardial infarction associated with Yasmin oral contraceptive.
    Ortí G; Mira Y; Vaya A
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):336-7. PubMed ID: 17636199
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on "Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review".
    Cameron S
    BJOG; 2013 Jun; 120(7):811. PubMed ID: 23802311
    [No Abstract]   [Full Text] [Related]  

  • 5. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review.
    Wu CQ; Grandi SM; Filion KB; Abenhaim HA; Joseph L; Eisenberg MJ
    BJOG; 2013 Jun; 120(7):801-10. PubMed ID: 23530659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female hormones and thrombosis.
    Rosendaal FR; Helmerhorst FM; Vandenbroucke JP
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):201-10. PubMed ID: 11834517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study.
    Lalude OO
    Curr Cardiol Rep; 2013 Jul; 15(7):374. PubMed ID: 23715878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use.
    Zakharova MY; Meyer RM; Brandy KR; Datta YH; Joseph MS; Schreiner PJ; Rao GH; Divani AA
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):323-31. PubMed ID: 20530058
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.